Suppr超能文献

表达非下调型表皮生长因子受体的NR6细胞的肿瘤发生增强。

Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors.

作者信息

Masui H, Wells A, Lazar C S, Rosenfeld M G, Gill G N

机构信息

Memorial Sloan Kettering Institute, New York, New York 10021.

出版信息

Cancer Res. 1991 Nov 15;51(22):6170-5.

PMID:1933876
Abstract

Sequences in the regulatory carboxyl terminus of the epidermal growth factor (EGF) receptor are required for ligand-induced internalization via a high-affinity saturable endocytic pathway and for receptor down-regulation. To investigate the role of down-regulation in attenuating mitogenic signals, we compared the ability of NR6 cells expressing holo and mutant down-regulation defective EGF receptors to form tumors in athymic mice. NR6 cells expressing mutant EGF receptors reproducibly formed rapidly growing tumors, whereas cells expressing holo EGF receptors had a low tumorigenic potential. Serial passage of tumors of NR6 cells expressing mutant EGF receptors resulted in an enhanced rate of tumor formation that directly correlated with increased expression of mutant receptors. Tumor growth was inhibited by a competitive antagonist anti-EGF receptor monoclonal antibody. Excessive signaling from the cell surface can result from lack of sequences required for endocytosis and from saturation of endocytic mechanisms. Non-down-regulating kinase-active EGF receptors provide an especially strong growth signal, manifested as rapid tumor growth in athymic mice.

摘要

表皮生长因子(EGF)受体调节性羧基末端的序列,对于通过高亲和力可饱和内吞途径进行的配体诱导的内化以及受体下调是必需的。为了研究下调在减弱有丝分裂信号中的作用,我们比较了表达完整和突变的下调缺陷型EGF受体的NR6细胞在无胸腺小鼠中形成肿瘤的能力。表达突变型EGF受体的NR6细胞可重复性地形成快速生长的肿瘤,而表达完整EGF受体的细胞具有较低的致瘤潜力。表达突变型EGF受体的NR6细胞肿瘤的连续传代导致肿瘤形成速率增加,这与突变型受体表达增加直接相关。肿瘤生长受到竞争性拮抗剂抗EGF受体单克隆抗体的抑制。细胞表面的过度信号传导可能源于内吞作用所需序列的缺失以及内吞机制的饱和。不进行下调的激酶活性EGF受体提供了特别强的生长信号,表现为无胸腺小鼠中肿瘤的快速生长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验